Nabla Bio
Signal active
Organization
Contact Information
Overview
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
About
Industries
Biotechnology, Machine Learning, Biopharma
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nabla Bio headquartered in United States, North America, operates in the Biotechnology, Machine Learning, Biopharma sector. The company focuses on Biotechnology and has secured $2.2B in funding across 60 round(s). With a team of 11-50 employees, Nabla Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Nabla Bio, raised $26.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
7
Lead Investors
0
Total Funding Amount
$37.4M
Details
3
Nabla Bio has raised a total of $37.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 125.0K | ||
| 2021 | Seed | 11.0M | ||
| 2024 | Early Stage Venture | 26.0M |
Investors
Nabla Bio is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Zetta Venture Partners | - | FUNDING ROUND - Zetta Venture Partners | 26.0M |
| Khosla Ventures | - | FUNDING ROUND - Khosla Ventures | 26.0M |
| Nabla Bio | - | FUNDING ROUND - Nabla Bio | 26.0M |
| Fifty Years | - | FUNDING ROUND - Fifty Years | 26.0M |
Recent Activity
There is no recent news or activity for this profile.